We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement.
- Authors
Mangione, Carol M.; Barry, Michael J.; Nicholson, Wanda K.; Cabana, Michael; Chelmow, David; Rucker Coker, Tumaini; Davidson, Karina W.; Davis, Esa M.; Donahue, Katrina E.; Jaén, Carlos Roberto; Kubik, Martha; Li, Li; Ogedegbe, Gbenga; Pbert, Lori; Ruiz, John M.; Stevermer, James; Wong, John B.; US Preventive Services Task Force
- Abstract
<bold>Importance: </bold>Current prevalence of obstructive sleep apnea (OSA) in the US is not well established; however, based on cohort and survey data, in 2007-2010 the estimated prevalence of at least mild OSA (defined as an apnea-hypoxia index [AHI] ≥5) plus symptoms of daytime sleepiness among adults aged 30 to 70 years was 14% for men and 5% for women, and the estimated prevalence of moderate to severe OSA (defined as AHI ≥15) was 13% for men and 6% for women. Severe OSA is associated with increased all-cause mortality. Other adverse health outcomes associated with untreated OSA include cardiovascular disease and cerebrovascular events, type 2 diabetes, cognitive impairment, decreased quality of life, and motor vehicle crashes.<bold>Objective: </bold>To update its 2017 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for OSA in adults.<bold>Population: </bold>Asymptomatic adults (18 years or older) and adults with unrecognized symptoms of OSA.<bold>Evidence Assessment: </bold>The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for OSA in the general adult population.<bold>Recommendation: </bold>The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for OSA in the general adult population. (I statement).
- Subjects
SLEEP apnea syndrome treatment; POLICY sciences; EVALUATION research; QUESTIONNAIRES; FERRANS &; Powers Quality of Life Index; SLEEP apnea syndromes; TYPE 2 diabetes; QUALITY of life; RESEARCH; RESEARCH methodology; MEDICAL screening; COMPARATIVE studies; DISEASE complications
- Publication
JAMA: Journal of the American Medical Association, 2022, Vol 328, Issue 19, p1945
- ISSN
0098-7484
- Publication type
journal article
- DOI
10.1001/jama.2022.20304